[1] 刘艳春,李伟,王欢, 等.染色体核型动态监测对急性白血病患者化疗疗效评估的作用[J].中国实验血液学杂志,2015,23(3):658-662. [2] BROWN P A,SHAH B,FATHI A,et al.NCCN guidelines insights:Acute lymphoblastic leukemia, version1.2017[J]. J Natl Compr Canc Netw,2017,15(9):1091-1102. [3] O'DONNELL M R,TALLMAN M S,ABBOUD C N,et al. NCCN clinical practice guidelines in oncology:Acute myeloid leukemia, version3.2017[J]. J Natl Compr Canc Netw,2017,15(7):926-957. [4] 中华医学会血液学分会白血病淋巴瘤学组.成人急性髓系白血病(非急性早幼粒细胞白血病)中国诊疗指南(2017年版)[J].中华血液学杂志,2017,38(3):177-182. [5] 中国抗癌协会血液肿瘤专业委员会,中华医学会血液学分会白血病淋巴瘤学组.中国成人急性淋巴细胞白血病诊断与治疗指南(2016年版)[J].中华血液学杂志,2016,37(10):837-845. [6] NISHIWAKI S,MIYAMURA K,OHASHI K,et al.Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia:a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation[J].Ann Oncol,2013,24(6):1594-1602. [7] STRICKLAND S A,SUN ZX,KETTERLING R P,et al.Independent prognostic significance of monosomy 17 and impact of karyotype complexity in monosomal karyotype/complex karyotype acute myeloid leukemia:results from four ECOG-ACRIN prospective therapeutic trials[J].Leuk Res,2017,59:55-64. [8] SEOL C A,CHO Y U,JANG S,et al.Prognostic significance of recurrent additional chromosomal abnormalities in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia[J].Cancer Genet,2017,216/217:29-36. [9] BYRD J C,MRÓZEK K,DODGE R K,et al.Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:results from Cancer and Leukemia Group B (CALGB 8461)[J].Blood,2002,100(13):4325-4336. [10] KURODA I,INUKAI T,ZHANG X,et al.BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia[J].Oncogene,2013,32(13):1670-1681. [11] 张之南,沈悌.血液病诊断及疗效标准[J].3版.北京:科学出版社,2007:103-121. [12] SCHWINGER E, LISA G,SHAFFER.Niels Tommerup:ISCN 2005:An international system for human cytogenetic nomenclature[J]. Ann Anat,2006,188(4):328. [13] HAFERLACH C,ALPERMANN T,SCHNITTGER S,et al.Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia:a study on 824 cases with aberrant karyotype[J].Blood,2012,119(9):2122-2125. [14] KAYSER S,ZUCKNICK M,DÖHNER K,et al.Monosomal karyotype in adult acute myeloid leukemia:prognostic impact and outcome after different treatment strategies[J].Blood,2012,119(2):551-558. [15] STÖLZEL F,MOHR B,KRAMER M,et al.Karyotype complexity and prognosis in acute myeloid leukemia[J].Blood Cancer J,2016,6:e386. [16] DANESHBOD Y,KOHAN L,TAGHADOSI V,et al.Prognostic significance of complex karyotypes in acute myeloid leukemia[J].Curr Treat Options Oncol,2019,20(2):15. [17] SHI L H,MA P,LIU J S,et al.Current views of chromosomal abnormalities in pediatric acute myeloid leukemia (AML)[J].Eur Rev Med Pharmacol Sci,2017,21(4 Suppl):25-30. [18] KAWAJIRI C,TANAKA H,HASHIMOTO S,et al.Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status[J].Int J Hematol,2014,99(4):513-518. [19] 丁懿,李萍,张文君,等.同济96方案序贯治疗Ph染色体阴性成人急性淋巴细胞白血病疗效分析[J].中华血液学杂志,2015,36(4):272-276. [20] KHORAL P,ATENAFU E G,CRADDOCK K J,et al.Prognostic effect of complex karyotype,monosomal karyotype, and chromosome 17 abnormalities in B-cell acute lymphoblastic leukemia[J].Clin Lymphoma Myeloma Leuk,2017,17(4):215-219. [21] MRÓZEK K,MARCUCCI G,NICOLET D,et al.Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia[J].J Clin Oncol,2012,30(36):4515-4523. |